Career Search
Explore opportunities with Novartis below.
Notice to applicants for US job openings. Learn More
Showing 853 results
- Sort by Sort ascending
- Job Title Sort ascending
- Business
- Location
- Site
- Date Posted
| Job Title Sort ascending | Business | Location | Site | Date Posted |
|---|---|---|---|---|
| Radioligand Therapies (RLT) Associate Director, Priority Accounts – Salt Lake City Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Jan 13, 2026 |
| Rheumatology Institutional Specialist – Chicago, IL Regular (Sales), Full time | Sales | USA +Alternative Locations | Field Sales (USA) | Jan 13, 2026 |
| Radioligand Therapies (RLT) Director, Ecosystem Lead – Northern CA Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Jan 13, 2026 |
| Associate Director - Foundry Solution Architecture, Full Stack & AIP Regular, Full time | Research | USA +Alternative Locations | Cambridge (USA) | Jan 13, 2026 |
| Radioligand Therapies (RLT) Director, Ecosystem Lead – Southern CA Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Jan 13, 2026 |
| Director, Oncology Priority Accounts - Nashville Regular, Full time | Development | USA +Alternative Locations | Field Non-Sales (USA) | Jan 13, 2026 |
| Program/Project Manager Regular, Full time | Marketing | Mexico | INSURGENTES | Jan 13, 2026 |
| Radioligand Therapies (RLT) Associate Director, Priority Accounts - Chicago Regular, Full time | General Management | USA +Alternative Locations | Field Non-Sales (USA) | Jan 13, 2026 |
| Elektriker/Elektrotechniker – HVAC Messstellenwartung (m/w/d), Schaftenau, Tirol, Österreich Regular, Part time | Production / Manufacturing | Austria | Kundl | Jan 13, 2026 |
| Analyst- Data Science Regular, Full time | Marketing | India | Hyderabad (Office) | Jan 13, 2026 |
Pagination
- ‹ Previous page
- 1
- …
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- …
- 86
- › Next page
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى